From the Departments of Pathology and Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque; and ZymoGenetics Inc, Seattle, WA.
Human tissue factor pathway inhibitor-2 (TFPI-2) is a matrix-associated Kunitz inhibitor that inhibits the plasmin- and trypsin-mediated activation of zymogen matrix metalloproteinases involved in tumor progression, invasion, and metastasis. To directly assess its role in tumor growth and metastasis in vivo, we stably transfected HT-1080 fibrosarcoma cells expressing either fully active wild-type human TFPI-2 (WT) or inactive R24Q TFPI-2 (QT) and examined their ability to form tumors and metastasize in athymic mice in comparison to mock-transfected cells (MT). MT and QT fibrosarcoma tumors grew 2 to 3 times larger than WT tumors. Tumor metastasis was confined to the lung and was observed in 75% of mice treated with either MT or QT cells, whereas only 42% of mice treated with WT cells developed lung metastases. Real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analyses of each tumor group revealed 3- to 6-fold lower levels of murine vascular endothelial growth factor gene expression in WT tumors in relation to either MT or QT tumors. Comparative tumor gene expression analysis revealed that several human genes implicated in oncogenesis, invasion, metastasis, apoptosis, and angiogenesis had significantly altered levels of expression in WT tumors. Our collective data demonstrate that secretion of inhibitory TFPI-2 by a highly metastatic tumor cell markedly inhibits its growth and metastasis in vivo by regulating pericellular extracellular matrix (ECM) remodeling and angiogenesis. (Blood. 2004;103:1069-1077)
Minimized closed circuit/centrifugal pump extracorporeal circulation: an effective aid in coronary bypass operations in Jehovah's Witnesses
Brain natriuretic peptide – a reliable parameter for the effectiveness of cardiac resynchronization therapy after coronary artery bypass grafting
Endoscopic thoracic sympathectomy – its effect in the treatment of refractory angina pectoris
Papillary muscle approximation combined with ventriculoplasty in patients with ischemic cardiomyopathy and functional mitral regurgitation: effects on mitral valve and LV shape
Is sildenafil effective for treating pulmonary hypertension after pediatric heart surgery
Effect of topic defibrillation on serum markers of myocardial damage
Improvement in cost-effectiveness and customer satisfaction by a quality management system according to EN ISO 9001:2000
Continuous subglottic suction is effective for prevention of ventilator associated pneumonia
Is Sotalol more effective than standard beta-blockers for the prophylaxis of atrial fibrillation during cardiac surgery
The effects of cardiac cooling under surface-induced hypothermia on the cardiac function in the in situ heart